Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines
Related Articles
-
People With More COVID-19 Vaccine Doses More Likely To Contract COVID-19: Study
People With More COVID-19 Vaccine Doses More Likely To Contract COVID-19: Study Authored by Zachary Stieber via The Epoch Times (emphasis ours), People who received more than one dose of a COVID-19 vaccine were more likely to contract COVID-19, according to a new study. A health care worker fills a syringe with Pfizer's COVID-19 vaccine in an undated file image. (Robyn Beck/AFP via Getty Images) An analysis of data from Cleveland Clinic employees found that people who received two...
-
Fall COVID-19 vaccine guidelines are out. Here’s what NACI recommends
The National Advisory Committee on Immunization released its updated guidelines on Friday for a COVID-19 vaccine rollout in the fall.
-
CDC Found Evidence COVID-19 Vaccines Caused Deaths
CDC Found Evidence COVID-19 Vaccines Caused Deaths Authored by Zachary Stieber via The Epoch Times (emphasis ours), U.S. Centers for Disease Control and Prevention (CDC) officials found evidence that the Pfizer-BioNTech and Moderna COVID-19 vaccines caused multiple deaths before claiming that there was no evidence linking the vaccines to any deaths, The Epoch Times has learned. (Illustration by The Epoch Times, Getty Images, Envato Elements) CDC employees worked to track down...